A ccelerated coronary atherosclerosis contributes to the increased mortality associated with type 2 diabetes. 1 Its determinants include hyperglycemia, hyperlipidemia, obesity, hypertension, and insulin resistance. 2 Coronary microvascular changes are common, often preceded by retinopathy. 3 Perivascular arteriolar fibrosis is often present in the hearts of patients with manifestations of myocardial ischemia despite the absence of marked stenosis demonstrable angiographically. 4 Thus, coronary microcirculatory abnormalities may be caused by insulin resistance typical of that seen with type 2 diabetes, characterized also by abnormalities in the hemostatic and fibrinolytic systems. In addition to increased concentrations in blood of plasminogen activator inhibitor type 1 (PAI-1), the primary physiological inhibitor of fibrinolysis, 5 concentrations of tissue factor (TF), an important initiator of coagulation, are increased. 6 Both may influence vascular remodeling. 7, 8 Interactions of cell surface-mediated generation of plasmin with extracellular matrix may alter both cell migration and turnover of matrix. 9 The present study was designed to characterize expression of proteins involved in the fibrinolytic and coagulation systems in relation to coronary microvascular changes in genetically obese mice (ob/ob) that develop insulin resistance and non-insulin-dependent diabetes mellitus 10 and to determine whether the inhibitor of ACE activity, known to lower PAI-1 concentrations, 11, 12 attenuates PAI-1 expression, perivascular fibrosis, or both in obese mice.
Methods

Experimental Animals and Morphometric Analysis
Experiments were in conformity with the guidelines of Hokkaido University and were approved by the Institutional Animal Study committee. Adult male obese mice (C57BL/6Job/ob) 8 weeks old and their lean littermates, obtained from the Jackson Laboratory (Bar Harbor, Me), had free access to chow and water. In some experiments, obese mice were given temocapril hydrochloride (Sankyo) in drinking water (20 mg · kg Ϫ1 · d Ϫ1 ) to induce ACE inhibition beginning when they were 10 weeks old and continuing for 10 weeks. In animals 10 weeks of age (10 control and 10 obese mice) and in animals 20 weeks of age (10 control, 10 obese, and 7 temocapriltreated), anesthesia was induced with ether. Blood samples were drawn from the left ventricle. The hearts were perfused with PBS, excised, rinsed in PBS, and weighed. A portion of the left ventricle was embedded into O.C.T. compound (Miles), frozen in liquid nitrogen, stored at Ϫ80°C, cut into sections 10 m thick with a cryostat, and stained with elastica-Masson's trichrome. The remaining tissue was frozen in liquid nitrogen and stored at Ϫ80°C. Glucose and PAI-1 activity in blood were measured as described previously. 5 Insulin was assayed by ELISA specific for mouse insulin (Shibayagi). Left ventricular myocardium-embedded coronary luminal areas, vessel walls, and perivascular fibrosis were quantified as described previously. 13 Immunohistochemistry PAI-1 and TF were detected immunohistochemically with the streptavidin-biotin immunoperoxidase method (Nichirei). 14 In brief, frozen sections (10 m) fixed in acetone were immersed in 3% H 2 O 2 for 15 minutes and incubated with PBS containing 10% rabbit serum (for PAI-1) and 5% goat serum (for TF) to block nonspecific staining. The sections were rinsed with PBS and incubated with anti-mouse PAI-1 sheep IgG (American Diagnostica) or with antihuman TF guinea pig IgG 15 diluted 1:250. After a washing with PBS, the sections were incubated with biotinylated anti-sheep rabbit IgG (Chemicon) for PAI-1 and anti-guinea pig goat IgG (Vector) for TF. They were again washed with PBS, incubated with peroxidaselabeled streptavidin, reacted with 3,3Ј-diaminobenzidine, and counterstained with hematoxylin. Control staining was performed with isotype IgG as the primary antibody. Qualitative assessment of intensity of staining was performed with a visual grading scale (0 to ϩϩϩϩ). Cardiac sections were characterized by comparison with grading scale sections by 2 observers blinded to the categories of the animals. 16 Quantitative image analysis of the sections was performed as previously described 16 by observers blinded with respect to the groups of animals. The immunohistochemically stained slides were viewed with a light microscope, and digital gray-scale images were A, Fibrosis-to-lumen and fibrosis-to-wall ratios of coronary arteries with ID Ͻ100 m in lean control (nϭ10) and 10-week-old obese (nϭ10) mice. Top, Representative photograph of coronary arteries from control and obese mice. B, Fibrosis-to-lumen and fibrosis-to-wall ratios of coronary arteries with ID Ͻ100 m in lean control (nϭ10), obese (nϭ10), and 20-week-old obese mice treated with temocapril (nϭ7) for 10 weeks. Top, Representative photograph of coronary arteries in control, obese, and temocapril-treated obese mice. 
Expression of PAI-1 and TF mRNA
Total RNA isolated from left ventricular myocardium was used for first-strand cDNA synthesis. The reverse transcription-polymerase chain reaction (RT-PCR) with selected primers was used for amplification of PAI-1, TF, and ␤-actin mRNA as previously described. 17 PAI-1 and TF sequences were amplified in a thermal cycler (Perkin-Elmer) for 35 cycles. The quality of RNA preparation and cDNA synthesis was verified by amplifying DNA coding ␤-actin, a housekeeping protein, under the same conditions.
RT-PCR products were visualized on 2% agarose gels with ethidium bromide. Signals were digitized and evaluated with an optical scanner (GT-9500, Seiko) with density measured with the use of an NIH image program in the public domain (Research Services Branch, NIH). In situ hybridization was performed as previously described. 18 In brief, an 856-bp fragment of mouse PAI-1 (nucleotides 475 to 1330) derived from mouse PAI-1 cDNA was amplified by PCR and subcloned to pBluescript II SK (ϩ) vector (Stratagene). Sense and antisense probes were prepared by linearizing the constructs with appropriate restriction enzymes and transcribed in vitro in the presence of digoxigenin-UTP and digoxigenin-labeling mixture with either T7 or T3 RNA polymerase (Roche Diagnostic). Frozen sections were fixed in 4% paraformaldehyde/PBS and treated with 0.25% acetic anhydride. Sections were prehybridized with 200 L hybridization buffer (5ϫSSC, 50% formamide, 5ϫDenhardt's solution, and 500 g/mL tRNA) and hybridized with 40 ng of digoxigenin-labeled riboprobe in 100 L of hybridization buffer at 70°C for 16 hours. They were washed with 5ϫSSC at 70°C for 10 minutes, 0.2ϫSSC at 70°C for 60 minutes; treated with 0.1 mol/L maleic acid buffer for 5 minutes and 1% blocking reagent containing maleic buffer for 60 minutes; and incubated with alkaline phosphatase-labeled anti-digoxigenin antibody (1:5000) for 60 minutes (Roche Diagnostic). Signals were detected with X-Phosphate/nitro blue tetrazolium. Serial sections were hybridized with sense probe as negative controls.
Statistical Analysis
Comparisons between groups were performed by ANOVA with multiple comparisons (Fisher's protected least significance t test) with Stat View (Abacus Concepts). Morphological data were analyzed with nonparametric statistics (Kruskal-Wallis for ANOVA designs). Results expressed are meanϮSD. A value of PϽ0.05 was considered significant.
Results
Body Weight, Heart Weight, and Left Ventricular Weight At 10 weeks of age, obese mice exhibited a Ͼ2-fold increase in body weight compared with that of controls (Figure 1) . The difference was also significant in animals 20 weeks of age. Body weights of obese mice treated with temocapril were not significantly different from those of untreated obese mice. Left ventricular weight was also increased significantly in obese mice 10 and 20 weeks of age. Heart and left ventricular weights in obese mice treated with temocapril from 10 to 20 weeks of age were significantly less than those in untreated obese mice. 
Qualitative and Quantitative Image Analysis Results for PAI-1 and TF
Glucose and Insulin Concentrations and PAI-1 Activity in Blood
Morphometric Analysis
Considerable fibrosis was seen around coronary arterioles and small arteries in obese mice 10 and 20 weeks of age ( Figure 2) , with a significant increase in the fibrosis-to-lumen and fibrosis-to-wall ratios at 10 and 20 weeks of age compared with values in controls. Treatment with temocapril attenuated these increases.
Immunohistochemistry
Although only faint immunoreactivity of PAI-1 and TF was detected in microvessels of control mice 20 weeks of age, strong signals were seen in endothelium in obese mice 20 weeks of age ( Figure 3) . Immunoreactivity of PAI-1 and TF was less in the specimens from obese mice treated with temocapril from 10 to 20 weeks of age than in those from untreated obese mice. As shown in Figure 3 and in the (Figure 3 , Table) . Temocapril attenuated this increase as well (1.68Ϯ0.51 AU, PϽ0.005). Quantitative (automated image analysis) results were consistent with these observations visually (Table) . Thus, as shown in the Table and Figure 4 , PAI-1 and TF were increased in the obese mouse samples, and temocapril attenuated the increases. The abundance of PAI-1 or of TF relative to ␤-actin in hearts from obese and lean mice is shown in Figure 5 . PAI-1 mRNA was markedly increased in obese compared with lean mice 10 weeks of age. TF mRNA was increased as well, but less markedly. PAI-1 mRNA increased further in obese mice 20 weeks of age, as did TF mRNA. Treatment with temocapril significantly reduced the magnitude of the increase in PAI-1 mRNA and TF mRNA in obese mice, but not to control levels. Expression of ␤-actin mRNA was not altered. In situ hybridization demonstrated PAI-1 mRNA in medial layers within the arteries (Figure 6 ), consistent with our immunohistochemical results (Figures 3 and 4) . No positive signals were observed in the sense control sections.
Discussion
Diabetes and Hypofibrinolysis
Genetically modified mice that are rendered leptin-deficient develop obesity, insulin resistance, hyperinsulinemia, hyperglycemia, and mild non-insulin-dependent diabetes mellitus. 10 We found PAI-1 activity to be increased in blood as well, consistent with observations by others. 10 Protein was increased, as judged from immunochemical analysis in the coronary endothelium of obese compared with lean mice. The RT-PCR results were consistent with increased amplification of PAI-1 and TF mRNA from obese mice. In situ hybridization showed that vascular cells were the loci of PAI-1 expression.
Fibrinolytic system activity is diminished in diabetic and insulin-resistant nondiabetic human subjects, 5, 19 which may be attributable to several mechanisms, including hyperinsulinemia and oxidative stress. 20 -22 Tumor necrosis factor, which is increased in blood and adipose tissue with diabetes, increases PAI-1 production. 23 These factors may lead to impaired fibrinolysis well before the onset of diabetes.
Coronary Remodeling in Obese Mice
We found that obese mice exhibit increased perivascular fibrosis, perhaps reflecting the above alteration in local concentrations of fibrinolytic and coagulation system proteins. The increased PAI-1 is hypothesized to have attenuated generation of plasmin and reduced proteolysis of matrix. 9 The increased TF is hypothesized to have induced procoagulant activity, thereby providing a provisional fibrin matrix augmenting cell migration. 8, 24 Although blood pressure was not measured in animals in this study, leptin, the product of the ob gene, increases blood pressure 25 and is deficient in ob/ob mice. Furthermore, the blood pressure of obese-hyperglycemic C57BL/6 mice produced by breeding mice heterozygous for the obesity gene is normal. 26 Thus, it is unlikely that elevated blood pressure and its amelioration by temocapril accounted for our results.
Diabetic patients develop a paucity of coronary collaterals, indicative of limited angiogenesis. 27, 28 Because altered characteristics of left ventricular capillaries in streptozotocininduced (insulin-deficient) diabetic rats have been reported, 29 in a preliminary study we characterized capillary profiles in obese mice. Remodeling appeared to be constrained in the obese animals (unpublished observations).
By augmenting PAI-1 expression, angiotensin influences fibrinolytic and TGF-␤ activity. 11, 12 It can also inhibit insulin signaling. 30 In the present study, inhibition of ACE activity attenuated PAI-1 expression and microvascular remodeling. Thus, angiotensin II may increase expression of procoagulant and hypo(proteo)fibrinolytic effects in the heart associated with insulin resistance, which is potentially ameliorated by inhibition of ACE activity with attenuation of perivascular fibrosis in obese mice by reducing expression of PAI-1 and TF. [31] [32] [33] [34] [35] [36] These mechanisms may contribute to the favorable effects of inhibition of ACE activity seen in patients at high cardiovascular risk. 37 
